Purchase Order W81K0022P0034
- Not listed
- The Department of the Army Medical Command intends to award a firm fixed price sole source contract to Boston Scientific Corporation in the amount of $658,800. The contract is pursuant to Federal Acquisition Regulation 13.501(a)(1)(ii) for the delivery of TheraSphere, Boston Scientific's FDA-approved therapy utilizing yttrium-90 radioactive microspheres to treat primary liver cancer. Per the pre-solicitation notice, TheraSphere is the only approved treatment for this indication. The contract...
- The Defense Health Agency awarded a $420,000 firm fixed-price purchase order to Boston Scientific Corp for TheraSphere Yttrium 90 radiation treatment devices, with a completion date of September 30, 2025. The contract, awarded on October 1, 2024, supports the Interventional Radiology Department at Brooke Army Medical Center located at Fort Sam Houston, Texas. This award was issued as a sole-source contract under Federal Acquisition Regulation 13.501(a)(1)(ii) authority, recognizing Boston...
- The Department of Veterans Affairs awarded a $215,695 purchase order to Boston Scientific Corporation to provide TheraSphere Y-90 radioactive microspheres in unit dose form for treatment of hepatocellular carcinoma at the Phoenix VA Health Care System. This award was made non-competitively under the authority of FAR 6.302-1 as Boston Scientific was determined to be the only responsible source able to meet the agency's requirement for the ready-to-use radiopharmaceutical supplies as specified...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a sole source purchase order contract to Boston Scientific Corp, doing business as Boston Scientific, to provide a 12-month supply of Therasphere Yttrium-90 (Y-90) radiopharmaceutical doses. The $143,960.00 firm fixed price contract will support the Dayton VA Medical Center's Nuclear Medicine Department in treating hepatocellular carcinoma. As the exclusive manufacturer of Therasphere, Boston Scientific was...
- The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...
- Boston Scientific Corp has been awarded a delivery order valued at $19,545 under a Blanket Purchase Agreement with the Defense Health Agency for the supply of TheraSphere radiation treatment devices. The contract carries a firm fixed-price pricing structure with an ultimate completion date of September 30, 2026, and performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. This award was issued without a small business set-aside, allowing the contractor to compete...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biocompatibles, Inc., a division of Boston Scientific Corp. The $5,526,500.00 contract is for the delivery of TheraSphere Y-90 radioactive microspheres, a minimally invasive therapeutic radiopharmaceutical product used for cancer treatment. The contract has a completion date of September 30, 2024 and a firm fixed price pricing type. This order is part of a larger indefinite...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $286,000 firm fixed price purchase order to BTG International Inc., a division of Boston Scientific Corp., to provide 15 doses of TheraSphere radiopharmaceuticals. The doses will be used to treat veterans with hepatocellular carcinoma at the Nuclear Medicine Department of the Cleveland VA Medical Center over the one year period of performance from July 2020 through July 2021. A sole...
- Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside...
- This is a $388,500.00 firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Boston Scientific Corporation, doing business as Boston Scientific, a leading manufacturer of medical devices. The contract is for the supply of TheraSphere, a medical product used in interventional radiology treatments. The contract has an ultimate completion date of September 30, 2024. Boston Scientific is not a small business, and this contract does not have a set-aside designation....
The Department of the Army Medical Command awarded a $639,000 firm fixed price purchase order to Boston Scientific Corporation for TheraSphere doses. TheraSphere is an FDA-approved radioactive microsphere therapy used to treat primary liver cancer. The solicitation indicated intent to make a sole source award to Boston Scientific under FAR 13.501(a)(1)(ii) for supplying TheraSphere to treat patients at Regional Health Command Central medical facilities. Interested parties were provided until January 7, 2022 to submit capability statements for consideration, though award was made to Boston Scientific on January 10th for delivery of the therapy through September 30, 2022 at facilities located in Fort Sam Houston, Texas. The contract has no set aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
TheraSphere Y90 | W81K0022Q0006 | Department of the Army Medical Command | Special Notice 1/1 | 1/4/22, 3:12 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $639.0k | 1/11/22 |